NOVO.B.DK

245.7

-0.87%↓

GMAB.DK

1,743

-1.64%↓

HLUNB.DK

42.96

-0.56%↓

ZEAL.DK

305.3

-0.03%↓

AMBUB.DK

66.25

-2.72%↓

NOVO.B.DK

245.7

-0.87%↓

GMAB.DK

1,743

-1.64%↓

HLUNB.DK

42.96

-0.56%↓

ZEAL.DK

305.3

-0.03%↓

AMBUB.DK

66.25

-2.72%↓

NOVO.B.DK

245.7

-0.87%↓

GMAB.DK

1,743

-1.64%↓

HLUNB.DK

42.96

-0.56%↓

ZEAL.DK

305.3

-0.03%↓

AMBUB.DK

66.25

-2.72%↓

NOVO.B.DK

245.7

-0.87%↓

GMAB.DK

1,743

-1.64%↓

HLUNB.DK

42.96

-0.56%↓

ZEAL.DK

305.3

-0.03%↓

AMBUB.DK

66.25

-2.72%↓

NOVO.B.DK

245.7

-0.87%↓

GMAB.DK

1,743

-1.64%↓

HLUNB.DK

42.96

-0.56%↓

ZEAL.DK

305.3

-0.03%↓

AMBUB.DK

66.25

-2.72%↓

Search

Coloplast A-S (Class B)

Închisă

419.3 -0.43

Rezumat

Modificarea prețului

24h

Curent

Minim

417.9

Maxim

423.1

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

24.492

60.328

EPS

6.32

Randament dividend

5.28

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

5.28%

2.24%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-21B

98B

Deschiderea anterioară

419.73

Închiderea anterioară

419.3

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 apr. 2026, 00:00 UTC

Câștiguri

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24 apr. 2026, 00:00 UTC

Câștiguri

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23 apr. 2026, 23:47 UTC

Market Talk

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

23 apr. 2026, 23:43 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23 apr. 2026, 23:13 UTC

Achiziții, Fuziuni, Preluări

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23 apr. 2026, 22:33 UTC

Câștiguri

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23 apr. 2026, 22:17 UTC

Câștiguri

PLS Executed Offtake Agreement With Ronbay

23 apr. 2026, 22:17 UTC

Câștiguri

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23 apr. 2026, 22:16 UTC

Câștiguri

PLS Commences Commissioning of Midstream Demonstration Plant

23 apr. 2026, 22:15 UTC

Câștiguri

PLS Group Reaffirms FY26 Guidance for All Metrics

23 apr. 2026, 22:14 UTC

Câștiguri

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23 apr. 2026, 22:14 UTC

Câștiguri

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23 apr. 2026, 22:13 UTC

Câștiguri

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23 apr. 2026, 22:12 UTC

Câștiguri

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23 apr. 2026, 22:12 UTC

Câștiguri

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23 apr. 2026, 22:11 UTC

Câștiguri

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23 apr. 2026, 22:10 UTC

Câștiguri

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23 apr. 2026, 22:09 UTC

Câștiguri

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23 apr. 2026, 22:08 UTC

Câștiguri

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23 apr. 2026, 22:04 UTC

Câștiguri

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23 apr. 2026, 21:56 UTC

Market Talk
Câștiguri

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23 apr. 2026, 21:48 UTC

Achiziții, Fuziuni, Preluări

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23 apr. 2026, 21:27 UTC

Câștiguri

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23 apr. 2026, 21:25 UTC

Câștiguri

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23 apr. 2026, 21:24 UTC

Câștiguri

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23 apr. 2026, 21:24 UTC

Câștiguri

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23 apr. 2026, 21:21 UTC

Câștiguri

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23 apr. 2026, 21:21 UTC

Câștiguri

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat